709
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, biological evaluation, and computational studies of N-benzyl pyridinium–curcumin derivatives as potent AChE inhibitors with antioxidant activity

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Article: 2281264 | Received 07 Sep 2023, Accepted 05 Nov 2023, Published online: 20 Nov 2023

References

  • 2023 Alzheimer’s disease facts and figures. Alzheimers Dement. 2023;19(4):1598–1695.
  • Rahman A, Hossen MA, Chowdhury MFI, Bari S, Tamanna N, Sultana SS, Haque SN, Al Masud A, Saif-Ur-Rahman KM. Aducanumab for the treatment of Alzheimer’s disease: a systematic review. Psychogeriatrics. 2023;23(3):512–522.
  • van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, et al. Lecanemab in early Alzheimer’s disease. N Engl J Med. 2023;388(1):9–21.
  • Chen ZR, Huang JB, Yang SL, Hong FF. Role of cholinergic signaling in Alzheimer’s disease. Molecules. 2022;27(6):1816. doi:10.3390/molecules27061816.
  • Inestrosa NC, Alvarez A, Pérez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into alzheimer’s fibrils: Possible role of the peripheral site of the enzyme. Neuron. 1996;16(4):881–891.
  • Carvajal FJ, Inestrosa NC. Interactions of ache with aβ aggregates in Alzheimer’s brain: Therapeutic relevance of idn 5706. Front Mol Neurosci. 2011;4(:19.
  • Kareem RT, Abedinifar F, Mahmood EA, Ebadi AG, Rajabi F, Vessally E. The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s agents: highlights from 2010 to 2020. RSC Adv. 2021;11(49):30781–30797.
  • Eissa KI, Kamel MM, Mohamed LW, Kassab AE. Development of new Alzheimer’s disease drug candidates using donepezil as a key model. Arch Pharm. 2023;356(1):2200398.
  • Mostofi M, Mohammadi Ziarani G, Mahdavi M, Moradi A, Nadri H, Emami S, Alinezhad H, Foroumadi A, Shafiee A. Synthesis and structure-activity relationship study of benzofuran-based chalconoids bearing benzylpyridinium moiety as potent acetylcholinesterase inhibitors. Eur J Med Chem. 2015;103(:361–369.
  • Wang C, Wu Z, Cai H, Xu S, Liu J, Jiang J, Yao H, Wu X, Xu J. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing n-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors. Bioorg Med Chem Lett. 2015;25(22):5212–5216.
  • Jabir NR, Khan FR, Tabrez S. Cholinesterase targeting by polyphenols: a therapeutic approach for the treatment of Alzheimer’s disease. CNS Neurosci Ther. 2018;24(9):753–762.
  • Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005;280(7):5892–5901.
  • Ramalakshmi N, R SR, C NN. Multitarget directed ligand approaches for Alzheimer’s disease: a comprehensive review. Mini Rev Med Chem. 2021;21(16):2361–2388.
  • Maramai S, Benchekroun M, Gabr MT, Yahiaoui S. Multitarget therapeutic strategies for Alzheimer’s disease: review on emerging target combinations. Biomed Res Int. 2020;2020(:5120230–27.
  • Yücel YY, Tacal O, Ozer I. Comparative effects of cationic triarylmethane, phenoxazine and phenothiazine dyes on horse serum butyrylcholinesterase. Arch Biochem Biophys. 2008;478(2):201–205.
  • Ganeshpurkar A, Singh R, Shivhare S, Kumar D, Gutti G, Singh R, Kumar A, Singh  , SK. Divya Improved machine learning scoring functions for identification of electrophorus electricus’s acetylcholinesterase inhibitors. Mol Divers. 2022;26(3):1455–1479.
  • Sugimoto H, Ogura H, Arai Y, Limura Y, Yamanishi Y. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J Pharmacol. 2002;89(1):7–20.
  • Ahmed M, Rocha JBT, Corrêa M, Mazzanti CM, Zanin RF, Morsch ALB, Morsch VM, Schetinger MRC. Inhibition of two different cholinesterases by tacrine. Chem Biol Interact. 2006;162(2):165–171.
  • Liston DR, Nielsen JA, Villalobos A, Chapin D, Jones SB, Hubbard ST, Shalaby IA, Ramirez A, Nason D, White WF. Pharmacology of selective acetylcholinesterase inhibitors: implications for use in alzheimer’s disease. Eur J Pharmacol. 2004;486(1):9–17.
  • Darras FH, Pang Y-P. On the use of the experimentally determined enzyme inhibition constant as a measure of absolute binding affinity. Biochem Biophys Res Commun. 2017;489(4):451–454.
  • Xiao F, Xu T, Lu B, Liu R. Guidelines for antioxidant assays for food components. Food Frontiers. 2020;1(1):60–69.
  • Trott O, Olson AJ. Autodock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461.
  • Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. Ucsf chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–1612.